BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19892038)

  • 1. The environment, geoepidemiology and ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Autoimmun Rev; 2010 Mar; 9(5):A293-8. PubMed ID: 19892038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antineutrophil cytoplasmic antibody(ANCA)].
    Yoshida M
    Rinsho Byori; 2003 Jul; 51(7):644-8. PubMed ID: 12924248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular manifestations of ANCA-associated vasculitis.
    Kubal AA; Perez VL
    Rheum Dis Clin North Am; 2010 Aug; 36(3):573-86. PubMed ID: 20688251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antineutrophil cytoplasm antibodies (ANCA): description and immunopathological role].
    Noël LH
    Ann Med Interne (Paris); 2000 May; 151(3):178-83. PubMed ID: 10896969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of pulmonary vasculitis.
    Heeringa P; Schreiber A; Falk RJ; Jennette JC
    Semin Respir Crit Care Med; 2004 Oct; 25(5):465-74. PubMed ID: 16088492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA genes in ANCA-associated vasculitides.
    Griffith ME; Pusey CD
    Exp Clin Immunogenet; 1997; 14(3):196-205. PubMed ID: 9493788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The history of ANCA-associated vasculitis.
    Ball GV
    Rheum Dis Clin North Am; 2010 Aug; 36(3):439-46. PubMed ID: 20688242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of ANCA-associated vasculitides].
    Mouthon L; Millet A; Régent A; Pederzoli-Ribeil M; Witko-Sarsat V
    Presse Med; 2012 Oct; 41(10):996-1003. PubMed ID: 22921085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases.
    Wiik A; Brimnes J; Heegaard NH
    Isr Med Assoc J; 1999 Sep; 1(1):4-7. PubMed ID: 11370121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.